2024 Q3 Form 10-Q Financial Statement

#000170968224000053 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $447.2M $423.0M
YoY Change 2.96% -7.4%
Cost Of Revenue $355.4M $333.7M
YoY Change 8.62% -3.6%
Gross Profit $91.83M $89.27M
YoY Change -14.3% -19.3%
Gross Profit Margin 20.53% 21.1%
Selling, General & Admin $54.63M $55.70M
YoY Change -4.08% -4.02%
% of Gross Profit 59.49% 62.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $59.31M $57.80M
YoY Change 8.63% 4.25%
% of Gross Profit 64.59% 64.75%
Operating Expenses $68.79M $71.59M
YoY Change -0.51% 0.77%
Operating Profit $23.04M $17.67M
YoY Change -39.39% -55.34%
Interest Expense -$43.88M -$42.40M
YoY Change 28.5% 34.07%
% of Operating Profit -190.45% -239.91%
Other Income/Expense, Net -$41.06M -$39.08M
YoY Change 44.57% 47.05%
Pretax Income -$18.02M -$21.41M
YoY Change -287.47% -264.7%
Income Tax -$604.0K $3.070M
% Of Pretax Income
Net Earnings -$17.42M -$24.48M
YoY Change -289.72% -310.84%
Net Earnings / Revenue -3.89% -5.79%
Basic Earnings Per Share -$0.07 -$0.10
Diluted Earnings Per Share -$0.07 -$0.10
COMMON SHARES
Basic Shares Outstanding 236.2M shares 240.4M shares
Diluted Shares Outstanding 234.4M shares 239.7M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.438M $8.059M
YoY Change -4.11% -80.92%
Cash & Equivalents $8.438M $8.059M
Short-Term Investments
Other Short-Term Assets $13.57M $20.04M
YoY Change -35.37% -27.35%
Inventory $1.201B $1.170B
Prepaid Expenses
Receivables $176.0M $166.7M
Other Receivables $11.99M $15.22M
Total Short-Term Assets $1.411B $1.381B
YoY Change 26.34% 34.14%
LONG-TERM ASSETS
Property, Plant & Equipment $1.186B $1.152B
YoY Change 8.06% 5.84%
Goodwill $705.3M $705.2M
YoY Change 0.21% 0.17%
Intangibles $259.5M $266.1M
YoY Change -8.67% -8.56%
Long-Term Investments
YoY Change
Other Assets $17.92M $19.63M
YoY Change -28.63% -24.22%
Total Long-Term Assets $2.169B $2.143B
YoY Change 2.75% 1.59%
TOTAL ASSETS
Total Short-Term Assets $1.411B $1.381B
Total Long-Term Assets $2.169B $2.143B
Total Assets $3.580B $3.524B
YoY Change 10.91% 12.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $88.74M $119.8M
YoY Change -31.98% 2.29%
Accrued Expenses $58.41M $53.35M
YoY Change -19.5% -20.42%
Deferred Revenue $20.06M $22.48M
YoY Change -11.4% -25.29%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.458M $3.779M
YoY Change 13.37% 6.45%
Total Short-Term Liabilities $1.098B $1.065B
YoY Change 33.15% 45.97%
LONG-TERM LIABILITIES
Long-Term Debt $1.567B $1.528B
YoY Change 9.89% 7.25%
Other Long-Term Liabilities $44.26M $40.30M
YoY Change 37.45% 31.64%
Total Long-Term Liabilities $1.644B $1.602B
YoY Change 10.39% 7.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.098B $1.065B
Total Long-Term Liabilities $1.644B $1.602B
Total Liabilities $2.742B $2.667B
YoY Change 18.5% 20.17%
SHAREHOLDERS EQUITY
Retained Earnings -$614.1M -$596.7M
YoY Change 6.99% 2.32%
Common Stock $25.00K $25.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $837.5M $856.7M
YoY Change
Total Liabilities & Shareholders Equity $3.580B $3.524B
YoY Change 10.91% 12.26%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$17.42M -$24.48M
YoY Change -289.72% -310.84%
Depreciation, Depletion And Amortization $59.31M $57.80M
YoY Change 8.63% 4.25%
Cash From Operating Activities $16.53M $37.78M
YoY Change -1132.87% -854.0%
INVESTING ACTIVITIES
Capital Expenditures $113.3M $89.66M
YoY Change 42.33% -11.41%
Acquisitions
YoY Change
Other Investing Activities $47.10M $24.38M
YoY Change 27.64% -36.28%
Cash From Investing Activities -$66.20M -$65.28M
YoY Change 55.02% 3.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 49.81M 27.48M
YoY Change 352.78% -64.67%
NET CHANGE
Cash From Operating Activities 16.53M 37.78M
Cash From Investing Activities -66.20M -65.28M
Cash From Financing Activities 49.81M 27.48M
Net Change In Cash 137.0K -16.00K
YoY Change -100.41% -100.16%
FREE CASH FLOW
Cash From Operating Activities $16.53M $37.78M
Capital Expenditures $113.3M $89.66M
Free Cash Flow -$96.77M -$51.88M
YoY Change 19.17% -51.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
7026000 usd
CY2023Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
6564000 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
251411684 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
249903120 shares
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5259000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
ctos Acquisition Of Inventory Through Floor Plan Payables
AcquisitionOfInventoryThroughFloorPlanPayables
320325000 usd
ctos Acquisition Of Inventory Through Floor Plan Payables
AcquisitionOfInventoryThroughFloorPlanPayables
398447000 usd
ctos Repayment Of Floor Plan Payables
RepaymentOfFloorPlanPayables
256827000 usd
ctos Repayment Of Floor Plan Payables
RepaymentOfFloorPlanPayables
325891000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
888443000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13800000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
342000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1122000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3374000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
904837000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
11610000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2222000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3205000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4008000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
919472000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2024Q2 us-gaap Revenues
Revenues
423013000 usd
CY2023Q2 us-gaap Revenues
Revenues
456830000 usd
us-gaap Revenues
Revenues
834320000 usd
us-gaap Revenues
Revenues
908993000 usd
CY2024Q2 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
102385000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
320628000 usd
CY2023Q2 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
141161000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
315669000 usd
CY2023Q2 us-gaap Revenues
Revenues
456830000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
210157000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
624163000 usd
us-gaap Revenues
Revenues
834320000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
283051000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
625942000 usd
us-gaap Revenues
Revenues
908993000 usd
CY2024Q2 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
77000000.0 usd
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
112100000 usd
CY2024Q2 ctos Contract With Customer Other Receivable After Allowance For Credit Loss
ContractWithCustomerOtherReceivableAfterAllowanceForCreditLoss
89700000 usd
CY2023Q4 ctos Contract With Customer Other Receivable After Allowance For Credit Loss
ContractWithCustomerOtherReceivableAfterAllowanceForCreditLoss
103000000.0 usd
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
184804000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
232592000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18103000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17503000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
166701000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
215089000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
7000000.0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5700000 usd
CY2024Q2 ctos Contract With Customer Liability Current Deferred Rent
ContractWithCustomerLiabilityCurrentDeferredRent
2900000 usd
CY2024Q2 ctos Contract With Customer Liability Current Customer Deposits
ContractWithCustomerLiabilityCurrentCustomerDeposits
19500000 usd
CY2023Q4 ctos Contract With Customer Liability Current Customer Deposits
ContractWithCustomerLiabilityCurrentCustomerDeposits
25900000 usd
CY2023Q4 ctos Contract With Customer Liability Current Customer Deposits
ContractWithCustomerLiabilityCurrentCustomerDeposits
25900000 usd
ctos Contract With Customer Liability Customer Deposits Revenue Recognized
ContractWithCustomerLiabilityCustomerDepositsRevenueRecognized
25800000 usd
ctos Contract With Customer Customer Deposits Timing
ContractWithCustomerCustomerDepositsTiming
P1Y
CY2024Q2 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
1554000 usd
CY2023Q2 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
19603000 usd
us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
4572000 usd
us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
43775000 usd
CY2024Q2 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
1229000 usd
CY2023Q2 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
19415000 usd
us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
4051000 usd
us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
42640000 usd
CY2024Q2 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
325000 usd
CY2023Q2 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
188000 usd
us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
521000 usd
us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
1135000 usd
CY2024Q2 us-gaap Sales Type Lease Variable Lease Income
SalesTypeLeaseVariableLeaseIncome
5600000 usd
CY2023Q2 us-gaap Sales Type Lease Variable Lease Income
SalesTypeLeaseVariableLeaseIncome
7900000 usd
us-gaap Sales Type Lease Variable Lease Income
SalesTypeLeaseVariableLeaseIncome
11000000.0 usd
us-gaap Sales Type Lease Variable Lease Income
SalesTypeLeaseVariableLeaseIncome
15100000 usd
CY2024Q2 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
3300000 usd
CY2023Q2 us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
4400000 usd
us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
6000000.0 usd
us-gaap Sales Type Lease Interest Income Lease Receivable
SalesTypeLeaseInterestIncomeLeaseReceivable
7800000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1170486000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
985794000 usd
CY2024Q2 ctos Floor Plan Payables Trade Current
FloorPlanPayablesTradeCurrent
385501000 usd
CY2023Q4 ctos Floor Plan Payables Trade Current
FloorPlanPayablesTradeCurrent
253197000 usd
CY2024Q2 ctos Floor Plan Payables Non Trade Current
FloorPlanPayablesNonTradeCurrent
472611000 usd
CY2023Q4 ctos Floor Plan Payables Non Trade Current
FloorPlanPayablesNonTradeCurrent
409113000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
15400000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
28300000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
8100000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
14900000 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
1446675000 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Gross
PropertySubjectToOrAvailableForOperatingLeaseGross
1405532000 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
499045000 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Accumulated Depreciation
PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation
488828000 usd
CY2024Q2 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
947630000 usd
CY2023Q4 us-gaap Property Subject To Or Available For Operating Lease Net
PropertySubjectToOrAvailableForOperatingLeaseNet
916704000 usd
CY2024Q2 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2 reporting_unit
CY2024Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1551739000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1517799000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
19527000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
22406000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1532212000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1495393000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3779000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8257000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1528433000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1487136000 usd
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30200000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29300000 shares
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24478000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239727000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11610000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
246130000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
825000 shares
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-24478000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239727000 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
11610000 usd
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246955000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38813000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
240045000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25410000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
246090000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
842000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-38813000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
240045000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
25410000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
246932000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000 usd
CY2023Q3 ctos Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
25000000 usd
CY2024Q1 ctos Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
25000000 usd
CY2024Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3600000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4600000 shares
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
16700000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
23100000 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
700000 shares
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3200000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4300000 usd
CY2024Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
7400000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.030
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2300000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.080
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q2 us-gaap Revenues
Revenues
423013000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
44585000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
333746000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
89267000 usd
CY2023Q2 us-gaap Revenues
Revenues
456830000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
43616000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
346211000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
110619000 usd
us-gaap Revenues
Revenues
834320000 usd
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
88329000 usd
us-gaap Cost Of Revenue
CostOfRevenue
654344000 usd
us-gaap Gross Profit
GrossProfit
179976000 usd
us-gaap Revenues
Revenues
908993000 usd
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
83946000 usd
us-gaap Cost Of Revenue
CostOfRevenue
688713000 usd
us-gaap Gross Profit
GrossProfit
220280000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
89267000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
110619000 usd
us-gaap Gross Profit
GrossProfit
179976000 usd
us-gaap Gross Profit
GrossProfit
220280000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55697000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
58028000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
113692000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
115019000 usd
CY2024Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
6692000 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
6606000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
13270000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
13278000 usd
CY2024Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
3360000 usd
CY2023Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2721000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
6280000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
5371000 usd
CY2024Q2 ctos Merger Related Costs
MergerRelatedCosts
5844000 usd
CY2023Q2 ctos Merger Related Costs
MergerRelatedCosts
3689000 usd
ctos Merger Related Costs
MergerRelatedCosts
10690000 usd
ctos Merger Related Costs
MergerRelatedCosts
7149000 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-42401000 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-31625000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-80316000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-60801000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3319000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5048000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6581000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8999000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21408000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12998000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37691000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27661000 usd
CY2024Q2 us-gaap Assets
Assets
3523568000 usd
CY2023Q4 us-gaap Assets
Assets
3367797000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249000 usd

Files In Submission

Name View Source Status
0001709682-24-000053-index-headers.html Edgar Link pending
0001709682-24-000053-index.html Edgar Link pending
0001709682-24-000053.txt Edgar Link pending
0001709682-24-000053-xbrl.zip Edgar Link pending
a06302024ctosex311.htm Edgar Link pending
a06302024ctosex312.htm Edgar Link pending
a06302024ctosex32.htm Edgar Link pending
ctos-20240630.htm Edgar Link pending
ctos-20240630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
ctos-20240630_def.xml Edgar Link unprocessable
ctos-20240630_lab.xml Edgar Link unprocessable
ctos-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctos-20240630_cal.xml Edgar Link unprocessable
ctos-20240630_htm.xml Edgar Link completed